119 related articles for article (PubMed ID: 22739084)
21. Alpha1-adrenoceptor antagonists. 6. Structural optimization of pyridazinone-arylpiperazines. Study of the influence on affinity and selectivity of cyclic substituents at the pyridazinone ring and alkoxy groups at the arylpiperazine moiety.
Betti L; Corelli F; Floridi M; Giannaccini G; Maccari L; Manetti F; Strappaghetti G; Botta M
J Med Chem; 2003 Jul; 46(16):3555-8. PubMed ID: 12877594
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of 3-arylpiperazinylalkylpyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as novel, potent, and selective alpha1-adrenoceptor ligands.
Patanè E; Pittalà V; Guerrera F; Salerno L; Romeo G; Siracusa MA; Russo F; Manetti F; Botta M; Mereghetti I; Cagnotto A; Mennini T
J Med Chem; 2005 Apr; 48(7):2420-31. PubMed ID: 15801833
[TBL] [Abstract][Full Text] [Related]
23. 1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
Franchini S; Prandi A; Baraldi A; Sorbi C; Tait A; Buccioni M; Marucci G; Cilia A; Pirona L; Fossa P; Cichero E; Brasili L
Eur J Med Chem; 2010 Sep; 45(9):3740-51. PubMed ID: 20605276
[TBL] [Abstract][Full Text] [Related]
24. Computer--based drug design, synthesis and biological evaluation of new pyrimidinone derivatives linked to arylpiperazine and 2'-carbethoxy-biphenylylmethyl moeities as alpha1-adrenoceptor antagonists and angiotensin II AT1 receptor antagonists.
Ismail MA; Abou El Ella DA; Abouzid KA; Al-Ansary GH
Pharmazie; 2010 Nov; 65(11):794-800. PubMed ID: 21155384
[TBL] [Abstract][Full Text] [Related]
25. The hypotensive activity and alpha1-adrenoceptor antagonistic properties of some aroxyalkyl derivatives of 2-methoxyphenylpiperazine.
Kubacka M; Mogilski S; Filipek B; Marona H
Eur J Pharmacol; 2013 Jan; 698(1-3):335-44. PubMed ID: 23117089
[TBL] [Abstract][Full Text] [Related]
26. Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT
Kucwaj-Brysz K; Kurczab R; Jastrzębska-Więsek M; Żesławska E; Satała G; Nitek W; Partyka A; Siwek A; Jankowska A; Wesołowska A; Kieć-Kononowicz K; Handzlik J
Eur J Med Chem; 2018 Mar; 147():102-114. PubMed ID: 29425815
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and structure-activity relationships of a new model of arylpiperazines. 8. Computational simulation of ligand-receptor interaction of 5-HT(1A)R agonists with selectivity over alpha1-adrenoceptors.
López-Rodríguez ML; Morcillo MJ; Fernández E; Benhamú B; Tejada I; Ayala D; Viso A; Campillo M; Pardo L; Delgado M; Manzanares J; Fuentes JA
J Med Chem; 2005 Apr; 48(7):2548-58. PubMed ID: 15801844
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, crystal structure, biological evaluation and molecular docking studies of carbazole-arylpiperazine derivatives.
Xu W; Huang J; Shao B; Xu X; Jiang R; Yuan M
Bioorg Med Chem; 2016 Nov; 24(21):5565-5572. PubMed ID: 27663545
[TBL] [Abstract][Full Text] [Related]
29. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
[TBL] [Abstract][Full Text] [Related]
30. Alpha(1)-adrenoceptor antagonists. 4. Pharmacophore-based design, synthesis, and biological evaluation of new imidazo-, benzimidazo-, and indoloarylpiperazine derivatives.
Betti L; Botta M; Corelli F; Floridi M; Giannaccini G; Maccari L; Manetti F; Strappaghetti G; Tafi A; Corsano S
J Med Chem; 2002 Aug; 45(17):3603-11. PubMed ID: 12166933
[TBL] [Abstract][Full Text] [Related]
31. Exploring the neuroleptic substituent in octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for α(1)-adrenoceptors.
Kristensen JL; Püschl A; Jensen M; Risgaard R; Christoffersen CT; Bang-Andersen B; Balle T
J Med Chem; 2010 Oct; 53(19):7021-34. PubMed ID: 20857909
[TBL] [Abstract][Full Text] [Related]
32. 3-Arylpiperazinylethyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione derivatives as novel, high-affinity and selective alpha(1)-adrenoceptor ligands.
Pittalà V; Romeo G; Salerno L; Siracusa MA; Modica M; Materia L; Mereghetti I; Cagnotto A; Mennini T; Marucci G; Angeli P; Russo F
Bioorg Med Chem Lett; 2006 Jan; 16(1):150-3. PubMed ID: 16216506
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and molecular modeling of 1H-pyrrolopyrimidine-2,4-dione derivatives as ligands for the α1-adrenoceptors.
Pittalà V; Siracusa MA; Modica MN; Salerno L; Pedretti A; Vistoli G; Cagnotto A; Mennini T; Romeo G
Bioorg Med Chem; 2011 Sep; 19(17):5260-76. PubMed ID: 21802308
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and alpha(1)-adrenoceptor binding properties of new arylpiperazine derivatives bearing a flavone nucleus as the terminal heterocyclic molecular portion.
Betti L; Floridi M; Giannaccini G; Manetti F; Paparelli C; Strappaghetti G; Botta M
Bioorg Med Chem; 2004 Mar; 12(6):1527-35. PubMed ID: 15018926
[TBL] [Abstract][Full Text] [Related]
35. Search for new tools to combat Gram-negative resistant bacteria among amine derivatives of 5-arylidenehydantoin.
Handzlik J; Szymańska E; Alibert S; Chevalier J; Otrębska E; Pękala E; Pagès JM; Kieć-Kononowicz K
Bioorg Med Chem; 2013 Jan; 21(1):135-45. PubMed ID: 23218781
[TBL] [Abstract][Full Text] [Related]
36. Molecular design and synthesis of 1,4-disubstituted piperazines as α(1)-adrenergic receptor blockers.
Abou El-Ella DA; Hussein MM; Serya RA; Abdel Naby RM; Al-Abd AM; Saleh DO; El-Eraky WI; Abouzid KA
Bioorg Chem; 2014 Jun; 54():21-30. PubMed ID: 24727279
[TBL] [Abstract][Full Text] [Related]
37. Rational design, synthesis, biological evaluation, homology and docking studies of coumarin derivatives as α1 -adrenoceptor antagonists.
Zhou X; Chen YD; Wang T; Wang XB; Kong LY
Chem Biodivers; 2011 Jun; 8(6):1052-64. PubMed ID: 21674779
[TBL] [Abstract][Full Text] [Related]
38. Ligand-based pharmacophore model of N-Aryl and N-Heteroaryl piperazine alpha 1A-adrenoceptors antagonists using GALAHAD.
Zhao X; Yuan M; Huang B; Ji H; Zhu L
J Mol Graph Model; 2010 Sep; 29(2):126-36. PubMed ID: 20538497
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
[TBL] [Abstract][Full Text] [Related]
40. [[(Arylpiperazinyl)alkyl]thio]thieno[2,3-d]pyrimidinone derivatives as high-affinity, selective 5-HT1A receptor ligands.
Modica M; Santagati M; Russo F; Parotti L; De Gioia L; Selvaggini C; Salmona M; Mennini T
J Med Chem; 1997 Feb; 40(4):574-85. PubMed ID: 9046348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
